INS and type 1 diabetes mellitus: In contrast, individuals with type 1 diabetes are unable to regulate their own insulin levels following subcutaneous delivery, and they often exhibit diminished glucagon and epinephrine responses to hypoglycemia (14–20), thereby making them much more vulnerable to low blood glucose.